EW ISSUES IN THE FIELD OF FAM-ily violence generate as much controversy as screening women for intimate partner violence (IPV) in health care settings. 1,2 Herein, we use the term screening to refer to universal routine inquiry: "a standardized assessment of patients, regardless of their reasons for seeking medical attention," 1 aimed at identifying women who are experiencing or have recently experienced IPV.Proponents of screening emphasize the following as a rationale for its implementation: the high prevalence of IPV and associated impairment, 3,4 the high level of acceptability among women about such inquiry, 5,6 the availability of feasible screening techniques, 7,8 and the opportunity to offer support and refer-rals to patients once IPV is identified. 6,9 Organizations such as the US Preventive Services Task Force 10 and the Canadian Task Force on Preventive Health Care 11 have concluded that insufficient evidence exists to recom-For editorial comment see p 568.

clinicaltrials.gov Identifier: NCT00336297.

An increasing trend of racial/ethnic disparity in maternal hypertension rates occurred in New York State during the past decade. This trend was persistent after stratification according to SES and other risk factors. Additional research is needed to understand the factors contributing to this growing disparity.

These findings establish the critical importance of daily AUC/MIC ratios during the first 2 days of therapy. As with all observational studies, these findings should be interpreted cautiously and validated in a multicenter randomized trial before adoption into practice.